117 related articles for article (PubMed ID: 8962712)
1. Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Naruse K; Sasaki H; Mizuno K; Matsubara A; Kakuta H
Exp Physiol; 1995 Nov; 80(6):981-9. PubMed ID: 8962712
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
3. An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic rats.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Hara T; Takeuchi N; Inukai S; Kasama N; Fukasawa H
Eur J Clin Invest; 1995 Dec; 25(12):948-54. PubMed ID: 8719936
[TBL] [Abstract][Full Text] [Related]
4. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
Funada M; Okamoto I; Fujinaga Y; Yamana T
Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
Kato N; Mizuno K; Matsubara A; Nakano K; Kurono M; Yagihashi S
J Diabetes Complications; 1994; 8(1):27-32. PubMed ID: 8167384
[TBL] [Abstract][Full Text] [Related]
6. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
7. Effect of propionyl-L-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Hara T; Fukasawa H; Kakuta H; Sakamoto N
Eur J Pharmacol; 1996 Sep; 311(2-3):199-206. PubMed ID: 8891600
[TBL] [Abstract][Full Text] [Related]
8. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
9. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
MacGregor LC; Matschinsky FM
J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
[TBL] [Abstract][Full Text] [Related]
10. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
Akita M; Mizuno K; Matsubara A; Nakano K; Kurono M
Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453
[TBL] [Abstract][Full Text] [Related]
11. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes.
Lowitt S; Malone JI; Salem A; Kozak WM; Orfalian Z
Diabetes; 1993 Aug; 42(8):1115-8. PubMed ID: 8325441
[TBL] [Abstract][Full Text] [Related]
13. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
14. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
16. Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats.
Kozak WM; Marker NA; Elmer KK
Doc Ophthalmol; 1986; 64(4):355-77. PubMed ID: 2958262
[TBL] [Abstract][Full Text] [Related]
17. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
18. Effect of an aldose reductase inhibitor on abnormalities of electroretinogram and vascular factors in diabetic rats.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hara T; Hamada Y; Fukasawa H; Kakuta H; Sakamoto N
Eur J Pharmacol; 1997 May; 326(1):45-51. PubMed ID: 9178654
[TBL] [Abstract][Full Text] [Related]
19. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
20. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
